Arcutis Biotherapeutics Inc. logo

Arcutis Biotherapeutics Inc. (ARQT)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
28. 82
-0.28
-0.9622%
$
3.32B Market Cap
- P/E Ratio
- Div Yield
1.73M Volume
-3.88 Eps
$ 29.1
Previous Close
Add Transaction
Day Range
28.15 29.3
Year Range
19.3 31.77
Want to track ARQT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Arcutis Biotherapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Scott Schroeder
Scott Schroeder Longaeva Partners LP
344,796 $9.04M $9.73M $686,144.14 7.59%
BM
Berkeley Meredith Hughes Financial Services LLC
2 $47.33 $58.2 $10.87 22.97%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
8,657 $226,986 $245,728.94 $18,742.94 8.26%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
2,626 $40,822.53 $74,263.28 $33,440.75 81.92%
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
31,392 $911,623.7 $913,507.2 $1,883.5 0.21%
AS
Aryn Sands GK Wealth Management LLC
325 $7,926.75 $8,479.25 $552.5 6.97%
Jon Borer
Jon Borer Capitolis Liquid Global Markets LLC
500,000 $14.52M $14.12M -$397,500 -2.74%